|
Arnold J. Levine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2026 |
42,000 |
42,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Carol G. Gallagher
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2026 |
42,000 |
42,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Carol G. Gallagher
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
04 Jun 2026 |
42,000 |
42,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Carol G. Gallagher
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
04 Jun 2026 |
42,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Charles M. Baum
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2026 |
42,000 |
42,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Laurie D. Stelzer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2026 |
42,000 |
42,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Kirsten Flowers
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2026 |
42,000 |
42,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Robert Ticktin
|
General Counsel & COO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Mar 2026 |
319,270 |
319,270
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Deepika Jalota
|
Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Mar 2026 |
303,310 |
303,310
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Michael Carulli
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Mar 2026 |
240,000 |
240,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
David H. Mack
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
27 Oct 2025 |
220,643 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
David H. Mack
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.37 per share. |
27 Oct 2025 |
220,643 |
451,109
|
-
|
1.4 |
302,281
|
Common Stock |
|
Robert Ticktin
|
General Counsel & COO |
Sale of securities on an exchange or to another person at price $ 1.06 per share. |
01 Jul 2025 |
23,151 |
98,695
|
-
|
1.1 |
24,651
|
Common Stock |
|
Deepika Jalota
|
Chief Development Officer |
Sale of securities on an exchange or to another person at price $ 1.06 per share. |
01 Jul 2025 |
33,065 |
89,959
|
-
|
1.1 |
35,198
|
Common Stock |
|
Michael Carulli
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 1.06 per share. |
01 Jul 2025 |
28,249 |
60,146
|
-
|
1.1 |
30,077
|
Common Stock |
|
Arnold J. Levine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jun 2025 |
33,500 |
33,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Carol G. Gallagher
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jun 2025 |
33,500 |
33,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Carol G. Gallagher
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
05 Jun 2025 |
33,500 |
33,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Carol G. Gallagher
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
05 Jun 2025 |
33,500 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Charles M. Baum
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jun 2025 |
33,500 |
33,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Laurie D. Stelzer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jun 2025 |
33,500 |
33,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Kirsten Flowers
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jun 2025 |
33,500 |
33,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Deepika Jalota
|
Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
300,000 |
300,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Michael Carulli
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
265,000 |
265,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Deepika Jalota
|
Chief Development Officer |
Sale of securities on an exchange or to another person at price $ 1.50 per share. |
11 Sep 2024 |
7,218 |
118,283
|
-
|
1.5 |
10,853
|
Common Stock |
|
Michael Carulli
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 1.50 per share. |
11 Sep 2024 |
2,891 |
88,395
|
-
|
1.5 |
4,347
|
Common Stock |
|
Deepika Jalota
|
Chief Development Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Aug 2024 |
125,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Deepika Jalota
|
Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Aug 2024 |
90,774 |
90,774
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Deepika Jalota
|
Chief Development Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Aug 2024 |
68,100 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Deepika Jalota
|
Chief Development Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Aug 2024 |
22,674 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Deepika Jalota
|
Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Aug 2024 |
125,000 |
125,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Michael Carulli
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Aug 2024 |
75,000 |
75,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Michael Carulli
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Aug 2024 |
40,805 |
40,805
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Michael Carulli
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Aug 2024 |
27,200 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Michael Carulli
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Aug 2024 |
13,605 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Michael Carulli
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Aug 2024 |
75,000 |
75,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Arnold J. Levine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jun 2024 |
67,500 |
67,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Carol G. Gallagher
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
06 Jun 2024 |
67,500 |
67,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Carol G. Gallagher
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
06 Jun 2024 |
67,500 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Carol G. Gallagher
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jun 2024 |
67,500 |
67,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Charles M. Baum
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jun 2024 |
67,500 |
67,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Laurie D. Stelzer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jun 2024 |
67,500 |
67,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Kirsten Flowers
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jun 2024 |
67,500 |
67,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Jalota Deepika
|
Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2024 |
225,095 |
225,095
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Carulli Michael
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2024 |
82,220 |
91,286
|
-
|
|
0
|
Common Stock |
|
Carulli Michael
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2024 |
204,630 |
204,630
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Jalota Deepika
|
Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2024 |
95,555 |
125,501
|
-
|
|
0
|
Common Stock |
|
Arnold J. Levine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
21,500 |
21,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Carol G. Gallagher
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
21,500 |
21,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Carol G. Gallagher
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
08 Jun 2023 |
21,500 |
21,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Carol G. Gallagher
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
08 Jun 2023 |
21,500 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Charles M. Baum
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
21,500 |
21,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Laurie D. Stelzer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
21,500 |
21,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Kirsten Flowers
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
21,500 |
21,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Winston Kung
|
COO, CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 May 2023 |
150,000 |
150,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Leila Alland
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 May 2023 |
100,000 |
100,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Deepika Jalota
|
Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 May 2023 |
125,000 |
125,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Winston Kung
|
COO, CFO |
Gift of securities by or to the insider at price $ 0.00 per share. |
25 Nov 2022 |
2,560 |
10,600
|
-
|
|
0
|
Common Stock |
|
Carol G. Gallagher
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
04 Nov 2022 |
39,000 |
39,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Carol G. Gallagher
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
04 Nov 2022 |
39,000 |
39,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Carol G. Gallagher
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Nov 2022 |
39,000 |
39,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Leila Alland
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Sep 2022 |
52,200 |
52,200
|
-
|
|
0
|
Common Stock |
|
Deepika Jalota
|
SVP, Regulatory Affairs and QA |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Sep 2022 |
34,050 |
34,050
|
-
|
|
0
|
Common Stock |
|
Arnold J. Levine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Jun 2022 |
19,500 |
19,500
|
-
|
|
-
|
Stock option (right to buy) |
|
Laurie D. Stelzer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Jun 2022 |
19,500 |
19,500
|
-
|
|
-
|
Stock Option |
|
Kirsten Flowers
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Jun 2022 |
19,500 |
19,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Winston Kung
|
COO, CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Apr 2022 |
4,000 |
210,034
|
-
|
|
-
|
Stock Option (right to buy) |
|
Winston Kung
|
COO, CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. |
20 Apr 2022 |
4,000 |
10,600
|
-
|
3.2 |
12,880
|
Common Stock |
|
Winston Kung
|
COO, CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2022 |
104,400 |
104,400
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Leila Alland
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2022 |
104,400 |
104,400
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Deepika Jalota
|
SVP, Regulatory Affairs and QA |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2022 |
68,100 |
68,100
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Kirsten Flowers
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Jan 2022 |
32,677 |
32,677
|
-
|
|
-
|
Stock Option (right to buy) |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.15 per share. |
06 Oct 2021 |
800 |
1,101,283
|
-
|
30.2 |
24,120
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.08 per share. |
30 Sep 2021 |
100 |
1,102,083
|
-
|
30.1 |
3,008
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.10 per share. |
30 Sep 2021 |
11,541 |
1,102,183
|
-
|
30.1 |
347,384
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.03 per share. |
30 Sep 2021 |
2,978 |
1,113,724
|
-
|
30.0 |
89,429
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.11 per share. |
27 Sep 2021 |
1,753 |
1,122,410
|
-
|
30.1 |
52,783
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.04 per share. |
27 Sep 2021 |
5,708 |
1,116,702
|
-
|
30.0 |
171,468
|
Common Stock |
|
Arnold J. Levine
|
Director |
Sale of securities on an exchange or to another person at price $ 30.00 per share. |
22 Sep 2021 |
3,500 |
409,842
|
-
|
30 |
105,000
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.00 per share. |
22 Sep 2021 |
100 |
1,124,163
|
-
|
30 |
3,000
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.03 per share. |
17 Sep 2021 |
711 |
1,124,263
|
-
|
30.0 |
21,351
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.44 per share. |
09 Sep 2021 |
38,056 |
1,143,417
|
-
|
30.4 |
1,158,425
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.20 per share. |
09 Sep 2021 |
13,272 |
1,124,974
|
-
|
30.2 |
400,814
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 31.03 per share. |
09 Sep 2021 |
5,171 |
1,138,246
|
-
|
31.0 |
160,456
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.31 per share. |
09 Sep 2021 |
14,329 |
1,181,473
|
-
|
30.3 |
434,312
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 30.25 per share. |
09 Sep 2021 |
100 |
0
|
-
|
30.3 |
3,025
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Sep 2021 |
100 |
353,850
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Leila Alland
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. |
09 Sep 2021 |
100 |
100
|
-
|
3.9 |
390
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 30.25 per share. |
07 Sep 2021 |
3,900 |
0
|
-
|
30.3 |
117,975
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Sep 2021 |
3,900 |
353,950
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Leila Alland
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. |
07 Sep 2021 |
3,900 |
3,900
|
-
|
3.9 |
15,210
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.38 per share. |
31 Aug 2021 |
21,986 |
1,201,202
|
-
|
30.4 |
667,935
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.15 per share. |
31 Aug 2021 |
5,400 |
1,195,802
|
-
|
30.2 |
162,810
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.12 per share. |
31 Aug 2021 |
19,520 |
1,223,188
|
-
|
30.1 |
587,942
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 31.13 per share. |
26 Aug 2021 |
6,091 |
1,280,383
|
-
|
31.1 |
189,613
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.05 per share. |
26 Aug 2021 |
13,233 |
1,242,708
|
-
|
30.1 |
397,652
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 31.06 per share. |
26 Aug 2021 |
1,045 |
1,255,941
|
-
|
31.1 |
32,458
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.50 per share. |
26 Aug 2021 |
23,397 |
1,256,986
|
-
|
30.5 |
713,609
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.39 per share. |
26 Aug 2021 |
15,063 |
1,286,474
|
-
|
30.4 |
457,765
|
Common Stock |
|
Arnold J. Levine
|
Director |
Sale of securities on an exchange or to another person at price $ 29.50 per share. |
23 Aug 2021 |
3,500 |
413,342
|
-
|
29.5 |
103,250
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 31.01 per share. |
23 Aug 2021 |
13,526 |
1,585,953
|
-
|
31.0 |
419,441
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 31.08 per share. |
23 Aug 2021 |
14,490 |
1,599,479
|
-
|
31.1 |
450,349
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 31.06 per share. |
23 Aug 2021 |
700 |
1,613,969
|
-
|
31.1 |
21,742
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.66 per share. |
23 Aug 2021 |
23,138 |
1,614,669
|
-
|
30.7 |
709,411
|
Common Stock |
|
Winston Kung
|
COO, CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. |
19 Aug 2021 |
5,000 |
6,600
|
-
|
3.2 |
16,100
|
Common Stock |
|
Winston Kung
|
COO, CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Aug 2021 |
5,000 |
214,034
|
-
|
|
-
|
Stock Option (right to buy) |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.97 per share. |
18 Aug 2021 |
3,800 |
1,637,807
|
-
|
31.0 |
117,686
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 32.57 per share. |
18 Aug 2021 |
11,431 |
1,657,040
|
-
|
32.6 |
372,308
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.32 per share. |
18 Aug 2021 |
2,237 |
1,641,607
|
-
|
34.3 |
76,774
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 33.84 per share. |
18 Aug 2021 |
13,196 |
1,643,844
|
-
|
33.8 |
446,553
|
Common Stock |
|
Deepika Jalota
|
SVP, Regulatory Affairs and QA |
Sale of securities on an exchange or to another person at price $ 33.78 per share. |
17 Aug 2021 |
2,896 |
0
|
-
|
33.8 |
97,814
|
Common Stock |
|
Deepika Jalota
|
SVP, Regulatory Affairs and QA |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Aug 2021 |
2,896 |
87,320
|
-
|
|
-
|
Stock option (right to buy) |
|
Deepika Jalota
|
SVP, Regulatory Affairs and QA |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.53 per share. |
17 Aug 2021 |
2,896 |
2,896
|
-
|
3.5 |
10,223
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.66 per share. |
13 Aug 2021 |
1,500 |
1,721,676
|
-
|
34.7 |
51,990
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 33.93 per share. |
13 Aug 2021 |
15,746 |
1,668,471
|
-
|
33.9 |
534,262
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 33.21 per share. |
13 Aug 2021 |
15,276 |
1,684,217
|
-
|
33.2 |
507,316
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.54 per share. |
13 Aug 2021 |
2,599 |
1,699,493
|
-
|
34.5 |
89,769
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 33.80 per share. |
13 Aug 2021 |
19,584 |
1,702,092
|
-
|
33.8 |
661,939
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.22 per share. |
13 Aug 2021 |
25,786 |
1,723,176
|
-
|
34.2 |
882,397
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.54 per share. |
10 Aug 2021 |
2,600 |
1,796,937
|
-
|
35.5 |
92,404
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.83 per share. |
10 Aug 2021 |
1,971 |
1,748,962
|
-
|
34.8 |
68,650
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.35 per share. |
10 Aug 2021 |
11,565 |
1,750,933
|
-
|
34.4 |
397,258
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.04 per share. |
10 Aug 2021 |
34,439 |
1,762,498
|
-
|
34.0 |
1,172,304
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.76 per share. |
10 Aug 2021 |
17,905 |
1,799,537
|
-
|
34.8 |
622,378
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 32.66 per share. |
09 Aug 2021 |
2,049 |
224
|
-
|
32.7 |
66,914
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Aug 2021 |
4,000 |
357,850
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Leila Alland
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 36.69 per share. |
09 Aug 2021 |
224 |
0
|
-
|
36.7 |
8,219
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 35.06 per share. |
09 Aug 2021 |
2,198 |
1,802
|
-
|
35.1 |
77,070
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. |
09 Aug 2021 |
4,000 |
4,000
|
-
|
3.9 |
15,600
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 36.38 per share. |
05 Aug 2021 |
26,871 |
1,868,264
|
-
|
36.4 |
977,567
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 36.64 per share. |
05 Aug 2021 |
300 |
1,817,442
|
-
|
36.6 |
10,992
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 36.08 per share. |
05 Aug 2021 |
8,623 |
1,817,742
|
-
|
36.1 |
311,118
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.14 per share. |
05 Aug 2021 |
13,259 |
1,826,365
|
-
|
35.1 |
465,921
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 36.94 per share. |
05 Aug 2021 |
200 |
1,839,624
|
-
|
36.9 |
7,388
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 36.61 per share. |
05 Aug 2021 |
19,700 |
1,839,824
|
-
|
36.6 |
721,217
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 36.70 per share. |
05 Aug 2021 |
8,740 |
1,859,524
|
-
|
36.7 |
320,758
|
Common Stock |
|
Winston Kung
|
COO, CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. |
03 Aug 2021 |
4,500 |
6,100
|
-
|
3.2 |
14,490
|
Common Stock |
|
Winston Kung
|
COO, CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Aug 2021 |
4,500 |
219,034
|
-
|
|
-
|
Stock Option (right to buy) |
|
Winston Kung
|
COO, CFO |
Sale of securities on an exchange or to another person at price $ 33.82 per share. |
03 Aug 2021 |
4,500 |
1,600
|
-
|
33.8 |
152,178
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.10 per share. |
02 Aug 2021 |
17,175 |
1,929,060
|
-
|
35.1 |
602,843
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 36.80 per share. |
02 Aug 2021 |
5,249 |
1,895,135
|
-
|
36.8 |
193,163
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 36.22 per share. |
02 Aug 2021 |
28,676 |
1,900,384
|
-
|
36.2 |
1,038,645
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.21 per share. |
02 Aug 2021 |
1,760 |
1,946,235
|
-
|
34.2 |
60,210
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.74 per share. |
02 Aug 2021 |
100 |
1,947,995
|
-
|
34.7 |
3,474
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 33.80 per share. |
02 Aug 2021 |
30,145 |
1,948,095
|
-
|
33.8 |
1,018,901
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.74 per share. |
02 Aug 2021 |
13,031 |
1,978,240
|
-
|
34.7 |
452,697
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.76 per share. |
28 Jul 2021 |
8,724 |
1,993,571
|
-
|
35.8 |
311,970
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.73 per share. |
28 Jul 2021 |
2,300 |
1,991,271
|
-
|
35.7 |
82,179
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.73 per share. |
23 Jul 2021 |
4,839 |
2,002,830
|
-
|
35.7 |
172,897
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 36.00 per share. |
23 Jul 2021 |
11,988 |
2,007,669
|
-
|
36 |
431,568
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.61 per share. |
23 Jul 2021 |
535 |
2,002,295
|
-
|
35.6 |
19,051
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.61 per share. |
21 Jul 2021 |
200 |
2,019,657
|
-
|
35.6 |
7,122
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.82 per share. |
21 Jul 2021 |
18,672 |
2,019,857
|
-
|
35.8 |
668,831
|
Common Stock |
|
Winston Kung
|
COO, CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Jul 2021 |
4,500 |
223,534
|
-
|
|
-
|
Stock Option (right to buy) |
|
Winston Kung
|
COO, CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. |
08 Jul 2021 |
4,500 |
6,100
|
-
|
3.2 |
14,490
|
Common Stock |
|
Winston Kung
|
COO, CFO |
Sale of securities on an exchange or to another person at price $ 33.75 per share. |
08 Jul 2021 |
4,500 |
1,600
|
-
|
33.8 |
151,875
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 31.93 per share. |
07 Jul 2021 |
1,951 |
2,049
|
-
|
31.9 |
62,300
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 32.66 per share. |
07 Jul 2021 |
2,049 |
0
|
-
|
32.7 |
66,914
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. |
07 Jul 2021 |
4,000 |
4,000
|
-
|
3.9 |
15,600
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Jul 2021 |
4,000 |
361,850
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Arnold J. Levine
|
Director |
Sale of securities on an exchange or to another person at price $ 33.22 per share. |
21 Jun 2021 |
3,389 |
420,453
|
-
|
33.2 |
112,579
|
Common Stock |
|
Arnold J. Levine
|
Director |
Sale of securities on an exchange or to another person at price $ 34.08 per share. |
21 Jun 2021 |
111 |
420,342
|
-
|
34.1 |
3,783
|
Common Stock |
|
Winston Kung
|
COO, CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. |
04 Jun 2021 |
4,500 |
6,100
|
-
|
3.2 |
14,490
|
Common Stock |
|
Winston Kung
|
COO, CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2021 |
4,500 |
228,034
|
-
|
|
-
|
Stock Option (right to buy) |
|
Winston Kung
|
COO, CFO |
Sale of securities on an exchange or to another person at price $ 33.75 per share. |
04 Jun 2021 |
4,500 |
1,600
|
-
|
33.8 |
151,875
|
Common Stock |
|
Arnold J. Levine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Jun 2021 |
16,333 |
16,333
|
-
|
|
-
|
Stock option (right to buy) |
|
Laurie D. Stelzer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Jun 2021 |
16,333 |
16,333
|
-
|
|
-
|
Stock Option |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.80 per share. |
28 May 2021 |
5,100 |
2,038,529
|
-
|
35.8 |
182,580
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.66 per share. |
25 May 2021 |
7,487 |
2,043,629
|
-
|
35.7 |
266,986
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.91 per share. |
25 May 2021 |
8,518 |
2,051,116
|
-
|
35.9 |
305,881
|
Common Stock |
|
Arnold J. Levine
|
Director |
Sale of securities on an exchange or to another person at price $ 34.68 per share. |
20 May 2021 |
2,961 |
423,842
|
-
|
34.7 |
102,676
|
Common Stock |
|
Arnold J. Levine
|
Director |
Sale of securities on an exchange or to another person at price $ 33.57 per share. |
20 May 2021 |
539 |
426,803
|
-
|
33.6 |
18,092
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.65 per share. |
20 May 2021 |
2,911 |
2,101,503
|
-
|
35.6 |
103,777
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.84 per share. |
20 May 2021 |
19,774 |
2,081,729
|
-
|
35.8 |
708,700
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 36.03 per share. |
20 May 2021 |
22,095 |
2,059,634
|
-
|
36.0 |
796,083
|
Common Stock |
|
Arnold J. Levine
|
Director |
Sale of securities on an exchange or to another person at price $ 35.12 per share. |
12 May 2021 |
3,500 |
416,842
|
-
|
35.1 |
122,929
|
Common Stock |
|
Arnold J. Levine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 May 2021 |
5,781 |
5,781
|
-
|
|
-
|
Stock Option (right to buy) |
|
Winston Kung
|
COO, CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 May 2021 |
50,337 |
50,337
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Leila Alland
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 May 2021 |
4,000 |
365,850
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Leila Alland
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 May 2021 |
36,279 |
36,279
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Leila Alland
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 34.00 per share. |
12 May 2021 |
1,367 |
0
|
-
|
34.0 |
46,484
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 33.39 per share. |
12 May 2021 |
2,633 |
1,367
|
-
|
33.4 |
87,903
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. |
12 May 2021 |
4,000 |
4,000
|
-
|
3.9 |
15,600
|
Common Stock |
|
Deepika Jalota
|
SVP, Regulatory Affairs and QA |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 May 2021 |
22,674 |
22,674
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.67 per share. |
10 May 2021 |
1,787 |
2,104,414
|
-
|
35.7 |
63,742
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 34.80 per share. |
07 May 2021 |
3,842 |
158
|
-
|
34.8 |
133,702
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 May 2021 |
4,000 |
369,850
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Leila Alland
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 35.49 per share. |
07 May 2021 |
158 |
0
|
-
|
35.5 |
5,607
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. |
07 May 2021 |
4,000 |
4,000
|
-
|
3.9 |
15,600
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.64 per share. |
05 May 2021 |
600 |
2,106,201
|
-
|
35.6 |
21,384
|
Common Stock |
|
Winston Kung
|
COO, CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. |
03 May 2021 |
4,500 |
6,100
|
-
|
3.2 |
14,490
|
Common Stock |
|
Winston Kung
|
COO, CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 May 2021 |
4,500 |
232,534
|
-
|
|
-
|
Stock Option (right to buy) |
|
Winston Kung
|
COO, CFO |
Sale of securities on an exchange or to another person at price $ 33.75 per share. |
03 May 2021 |
4,500 |
1,600
|
-
|
33.8 |
151,875
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.89 per share. |
09 Apr 2021 |
19,858 |
2,110,704
|
-
|
34.9 |
692,846
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 33.11 per share. |
09 Apr 2021 |
100 |
2,106,801
|
-
|
33.1 |
3,311
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 32.00 per share. |
09 Apr 2021 |
900 |
2,106,901
|
-
|
32 |
28,800
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 31.17 per share. |
09 Apr 2021 |
2,903 |
2,107,801
|
-
|
31.2 |
90,487
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 33.75 per share. |
09 Apr 2021 |
5,905 |
2,130,562
|
-
|
33.8 |
199,294
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 33.86 per share. |
07 Apr 2021 |
3,972 |
28
|
-
|
33.9 |
134,481
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Apr 2021 |
4,000 |
373,850
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Leila Alland
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 34.43 per share. |
07 Apr 2021 |
28 |
0
|
-
|
34.4 |
964
|
Common Stock |
|
Leila Alland
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. |
07 Apr 2021 |
4,000 |
4,000
|
-
|
3.9 |
15,600
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.67 per share. |
06 Apr 2021 |
67,086 |
2,194,246
|
-
|
34.7 |
2,325,872
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.23 per share. |
06 Apr 2021 |
20,701 |
2,136,467
|
-
|
34.2 |
708,595
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 33.82 per share. |
06 Apr 2021 |
12,621 |
2,157,168
|
-
|
33.8 |
426,842
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.50 per share. |
06 Apr 2021 |
100 |
2,169,789
|
-
|
34.5 |
3,450
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 33.88 per share. |
06 Apr 2021 |
24,357 |
2,169,889
|
-
|
33.9 |
825,215
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 33.85 per share. |
06 Apr 2021 |
11,571 |
2,261,332
|
-
|
33.8 |
391,678
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 33.46 per share. |
01 Apr 2021 |
18,990 |
2,302,106
|
-
|
33.5 |
635,405
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.03 per share. |
01 Apr 2021 |
29,203 |
2,272,903
|
-
|
34.0 |
993,778
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 32.94 per share. |
01 Apr 2021 |
12,435 |
2,321,096
|
-
|
32.9 |
409,609
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 33.16 per share. |
29 Mar 2021 |
764 |
2,389,640
|
-
|
33.2 |
25,334
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 32.93 per share. |
29 Mar 2021 |
13,645 |
2,333,531
|
-
|
32.9 |
449,330
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 32.33 per share. |
29 Mar 2021 |
18,381 |
2,347,176
|
-
|
32.3 |
594,258
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 31.19 per share. |
29 Mar 2021 |
1,600 |
2,365,557
|
-
|
31.2 |
49,904
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 31.19 per share. |
29 Mar 2021 |
3,276 |
2,367,157
|
-
|
31.2 |
102,178
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 30.82 per share. |
29 Mar 2021 |
19,207 |
2,370,433
|
-
|
30.8 |
591,960
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 31.60 per share. |
29 Mar 2021 |
1,410 |
2,390,404
|
-
|
31.6 |
44,556
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 35.12 per share. |
24 Mar 2021 |
19,002 |
2,509,288
|
-
|
35.1 |
667,350
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 33.44 per share. |
24 Mar 2021 |
35,268 |
2,391,814
|
-
|
33.4 |
1,179,362
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.82 per share. |
24 Mar 2021 |
1,200 |
2,427,082
|
-
|
34.8 |
41,784
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 34.17 per share. |
24 Mar 2021 |
3,787 |
2,428,282
|
-
|
34.2 |
129,402
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 32.94 per share. |
24 Mar 2021 |
61,340 |
2,432,069
|
-
|
32.9 |
2,020,540
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 39.00 per share. |
24 Mar 2021 |
10,100 |
2,493,409
|
-
|
39 |
393,900
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 37.51 per share. |
24 Mar 2021 |
700 |
2,503,509
|
-
|
37.5 |
26,257
|
Common Stock |
|
Thilo Schroeder
|
Director |
Sale of securities on an exchange or to another person at price $ 36.53 per share. |
24 Mar 2021 |
5,079 |
2,504,209
|
-
|
36.5 |
185,536
|
Common Stock |
|
Winston Kung
|
COO, CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. |
08 Dec 2020 |
1,600 |
1,600
|
-
|
3.2 |
5,152
|
Common Stock |
|
Winston Kung
|
COO, CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Dec 2020 |
1,600 |
237,034
|
-
|
|
-
|
Stock Option (right to buy) |
|
Thilo Schroeder
|
Director, Ten Percent Owner |
|
29 Sep 2020 |
760,267 |
2,528,290
|
-
|
|
-
|
Common Stock |
|
Thilo Schroeder
|
Director, Ten Percent Owner |
|
29 Sep 2020 |
1,768,023 |
1,768,023
|
-
|
|
-
|
Common Stock |
|
Thilo Schroeder
|
Director, Ten Percent Owner |
|
29 Sep 2020 |
1,768,023 |
0
|
-
|
|
-
|
Series C Preferred Stock |
|
Thilo Schroeder
|
Director, Ten Percent Owner |
|
29 Sep 2020 |
760,267 |
0
|
-
|
|
-
|
Series D Preferred Stock |
|
Arnold L. Oronsky
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 18.00 per share. |
25 Sep 2020 |
55,555 |
55,555
|
-
|
18 |
999,990
|
Common Stock |
|
Arnold L. Oronsky
|
Director, Ten Percent Owner |
|
25 Sep 2020 |
265,203 |
0
|
-
|
|
-
|
Series C Preferred Stock |
|
Arnold L. Oronsky
|
Director, Ten Percent Owner |
|
25 Sep 2020 |
1,040,654 |
0
|
-
|
|
-
|
Series B Preferred Stock |
|
Arnold L. Oronsky
|
Director, Ten Percent Owner |
|
25 Sep 2020 |
3,488,398 |
0
|
-
|
|
-
|
Series A Preferred Stock |
|
Arnold L. Oronsky
|
Director, Ten Percent Owner |
|
25 Sep 2020 |
1,620,101 |
0
|
-
|
|
-
|
Series Seed Preferred Stock |
|
Arnold L. Oronsky
|
Director, Ten Percent Owner |
|
25 Sep 2020 |
265,203 |
6,469,911
|
-
|
|
-
|
Common Stock |
|
Arnold L. Oronsky
|
Director, Ten Percent Owner |
|
25 Sep 2020 |
1,040,654 |
6,204,708
|
-
|
|
-
|
Common Stock |
|
Arnold L. Oronsky
|
Director, Ten Percent Owner |
|
25 Sep 2020 |
3,488,398 |
5,164,054
|
-
|
|
-
|
Common Stock |
|
Arnold L. Oronsky
|
Director, Ten Percent Owner |
|
25 Sep 2020 |
1,620,101 |
1,675,656
|
-
|
|
-
|
Common Stock |